Beauty Farm Medical & Health Industry, Inc.

As of December 31, 2025, Beauty Farm Medical & Health Industry, Inc. carries a market capitalization of 6.39B, placing it among publicly traded companies globally. Its enterprise value stands at 5.05B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Beauty Farm Medical & Health Industry, Inc.'s next confirmed earnings release is scheduled for March 31, 2027.

As of December 31, 2025, Beauty Farm Medical & Health Industry, Inc. has 234.86M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Beauty Farm Medical & Health Industry, Inc. maintains a current ratio of 0.98, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Beauty Farm Medical & Health Industry, Inc.'s stock has declined approximately 44.37% over the past 52 weeks. The 50-day moving average sits at 18.32, while the 200-day moving average is 20.50.

As of December 31, 2025, Beauty Farm Medical & Health Industry, Inc. holds 2.83B in cash and equivalents against 1.44B in total debt, resulting in a net debt position of -420.38M. Total book value stands at 1.14B, with working capital of -57.45M providing operational flexibility.